Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2024-09-18EMA Authorised: Comtan (entacapone) — Orion Corporation
European Medicines Agency authorised Comtan (entacapone) for Parkinson disease with Orion Corporation as the marketing authorisation holder.
-
EMA approval · 2024-09-18EMA Authorised: Comtess (entacapone) — Orion Corporation
EMA has authorised Comtess (entacapone) by Orion Corporation for the treatment of Parkinson's disease; entacapone is a COMT inhibitor used a…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Longitudinal Analysis of Gait Variability to Predict Falls in Parkinson's Disease [NA]
This clinical trial update describes a longitudinal analysis of gait variability to predict falls in Parkinson disease, and the study has be…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation [NA]
ClinicalTrials.gov updates a study evaluating vibrotactile coordinated reset (vCR) therapy for advanced Parkinson disease in patients who pr…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: iDAP Injection in the Treatment of Parkinson's Disease [EARLY_Phase 1]
An early Phase 1 trial is evaluating iDAP injections for Parkinson's disease and is not yet recruiting. The sponsor listed is Anhui Provinci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: The Efficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease：A Randomized, Double-blind, Multicenter, Placebo-controlled Trial [NA]
This entry reports a randomized, double-blind, multicenter trial evaluating repetitive transcranial magnetic stimulation for Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients
This document reports the completion of a clinical trial that compared balance, activity-specific balance confidence, and quality of life in…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: NeuroGlove PD Study Clinical [EARLY_Phase 1]
A Phase 1 trial evaluating NeuroGlove for Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Exercise Neuroprotection in Parkinson's Disease [NA]
A clinical trial is currently recruiting to evaluate exercise-based neuroprotection in Parkinson's disease. The sponsor is the University of…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Vibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic Medication [NA]
A Stanford-led clinical trial is evaluating vibrotactile Coordinated Reset stimulation for Parkinson's disease patients on dopaminergic ther…
-
EMA approval · 2024-09-02EMA Authorised: Pramipexole Teva (pramipexole dihydrochloride monohydrate) — Teva Pharma B.V.
The EMA authorised Pramipexole Teva (pramipexole dihydrochloride monohydrate) for use in Parkinson disease, with Teva Pharma B.V. as the mar…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Exploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease [NA]
A Heidelberg University trial is investigating how exercise impacts memory and cognition in Parkinson disease. It is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease
This ClinicalTrials.gov entry describes a recruiting study evaluating whether continuous subcutaneous infusion of apomorphine improves perso…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Combined Genome and RNA Sequencing for Genetic Diagnosis of Parkinsonism [NA]
A clinical trial is evaluating combined genome and RNA sequencing for the genetic diagnosis of Parkinson's disease; the study is currently N…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: rTMS as an Intervention for Levodopa-induced Dyskinesia [NA]
This clinical trial update indicates that a study evaluating repetitive transcranial magnetic stimulation (rTMS) as a treatment for levodopa…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery [NA]
Clinical trial update for a study aiming to promote visual recovery by re-orchestrating interregional brain oscillations in individuals with…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)
This document reports the AI-PROGNOSIS dBM-DEV study, a Parkinson disease trial focused on developing digital biomarkers; the study is not y…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: A Multidimensional Study on Articulation Deficits in Parkinsons Disease
This clinical trial update reports the completion of a multidimensional study examining articulation deficits in Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease [EARLY_Phase 1]
An early-phase 1 trial completed evaluating how Vitamin D influences Th17 and Treg immune cells in Parkinson's disease, to explore a potenti…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: 24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]
This update describes an ongoing clinical trial evaluating the safety and efficacy of Peroneal Transcutaneous NeuroModulation in Parkinson's…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Effects of Rock Climbing on Parkinson's Disease
A completed clinical trial investigating the effects of rock climbing on Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]
Completed clinical trial evaluating safety and efficacy of peroneal transcutaneous neuro modulation in Parkinson's disease and essential tre…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Remotely Prescribed and Monitored Home-based Gait-and-balance Augmented Reality Exergaming for People With Parkinson's Disease. [NA]
A completed clinical trial from VU University of Amsterdam evaluated remotely prescribed, home-based gait and balance training using augment…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study [NA]
A clinical trial is evaluating whether non-invasive and invasive neuromodulation, including transcranial direct current stimulation, can imp…
-
EMA approval · 2024-08-20EMA Authorised: Oprymea (pramipexole dihydrochloride monohydrate) — Krka, d.d., Novo mesto
EMA has authorised Oprymea (pramipexole dihydrochloride monohydrate) for the treatment of Parkinson's disease, under the marketing authorisa…